Weight loss consultation Personalized consultation with a licensed doctor who can assess your individual needs and prescribe a GLP-1 medication, if appropriate
semaglutide users received 0.25 mg at first dispensation (51%)
In most ischemic stroke, there is a Middle Cerebral Artery (MCA) involvement
PlexusDx also offers microdose GLP-1 protocols and the GLP-Squared dual compound for patients seeking alternative approaches
Compared to usual care, participants who used GLP-1RAs had a lower risk of: substance use and psychotic disorders seizures neurocognitive disorders including Alzheimers disease and dementia infectious illnesses several respiratory conditions coagulation and cardiometabolic disorders, including deep vein thrombosis, pulmonary embolism, stroke, cardiac arrest, heart failure and myocardial infarction
It does not replace professional medical consultation, diagnosis, or treatment